| 日期 | 主要股東
| 每股
平均價 | 類型 | 買/賣或涉及
股份數目 | 變動股數
佔已發行股(%) | 目前持股量 | 佔已
發行股(%) |
| 2024-04-15 | 中國信達資產管理股份有限公司 | | 1004 (L) | 74,387,153(L) | N/A | 74387153(L) | 13.88(L) |
| 2024-04-12 | 煙檯綠葉醫葯控股（集團）有限公司 | | N/A
1701 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | Shorea LBG | | N/A
1701 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | 山東綠葉製葯有限公司 | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | Nelumbo Investments Limited | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | 綠葉製藥集團有限公司 | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | Luye Life Sciences Group Ltd | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | LuYe Pharmaceutical Investment Co., Ltd. | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | LuYe Pharmaceutical International Co., Ltd. | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | Luye Pharma Holdings Ltd. | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | Luye Pharma Hong Kong Limited | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | Ginkgo (PTC) Limited | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | AsiaPharm Investments Ltd. | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2024-04-12 | 劉殿波 | | N/A
1316 (S) | N/A
74,387,153(S) | N/A
N/A | 360596456(L)
74387153(S) | 70.81(L)
14.61(S) |
| 2022-12-30 | 劉元沖 | | 1701 (L) | 4,000,000(L) | N/A | 4000000(L) | 0.79(L) |